Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2025-12-24 @ 6:31 PM
NCT ID:
NCT02203357
Eligibility Criteria:
Inclusion Criteria:
* Healthy subjects aged between 16 and 25 as established by medical history and clinical examination
* Written informed consent will be obtained from each subject before the serum screening of HBV markers
* Seronegative for HBsAg, anti-HBs antibody, anti-HBc antibody
* Have never been immunized with HBV vaccine before
Exclusion Criteria:
* Subject has a medical history of allergic to any ingredient of vaccine
* Family history of seizures or progressive neurological disease
* Autoimmune disease or immunodeficiency
* Women with pregnant
* Bleeding disorder diagnosed by a doctor
* Chronic diseases: hepatitis, tumor, tuberculosis,et.al
* Any prior administration of immunoglobulins or blood products in the last 3 mon before recruitment
* Subjects had a medical history of serious adverse reactions to vaccines
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
25 Years
Study:
NCT02203357
Study Brief:
Protocol Section:
NCT02203357